Doctronic Raises $40M Series B Following Breakthrough as First AI to Legally Renew Prescriptions in the U.S.

Doctronic在成为美国首个合法续方处方的AI后，完成4000万美元B轮融资。

Round co-led by Abstract and Lightspeed follows 15× growth and more than 300,000 weekly users in under a year

由Abstract和Lightspeed共同领投的本轮投资，是在不到一年的时间里，用户周活增长15倍并超过30万之后进行的。

NEW YORK, March 24, 2026-- Doctronic, the first AI system legally authorized to practice medicine in the United States, today announced a $40 million Series B round co-led by Abstract and Lightspeed Venture Partners, with participation from existing investors including Union Square Ventures, Seven Stars, Mantis, and Tusk Ventures.

纽约，2026年3月24日——美国首个获法律授权行医的AI系统Doctronic今日宣布完成4000万美元的B轮融资，本轮融资由Abstract和Lightspeed Venture Partners共同领投，现有投资者Union Square Ventures、Seven Stars、Mantis和Tusk Ventures亦有参与。

The financing—Doctronic's third round in less than 12 months—brings total funding to more than $65 million..

这笔融资——Doctronic在不到12个月内的第三轮融资——使其总融资额超过6500万美元。

The funding follows a period of exceptional growth. In less than six months since closing the Series A, Doctronic has grown 15x to 8-figure annualized revenue, while nearly tripling repeat patient rate. Doctronic now sees more than 300,000 unique weekly visitors. In December, the company became the first AI-native platform to autonomously renew prescriptions under Utah's AI Learning Lab regulatory sandbox.

这笔资金的注入是在一段异常强劲的增长之后。在完成A轮融资后的不到六个月内，Doctronic的年化收入增长了15倍，达到八位数，同时回头患者率几乎增加了两倍。Doctronic现在每周有超过30万名独立访客。去年12月，该公司成为首家在犹他州AI学习实验室监管沙盒下自主续方的原生人工智能平台。

Doctronic now serves health systems, payers, and employers through cobranded digital health partnerships while maintaining its direct-to-consumer platform used by millions nationwide..

Doctronic现在通过联合品牌数字健康合作伙伴关系为卫生系统、支付方和雇主提供服务，同时继续维持其在全国范围内被数百万用户使用的直接面向消费者的平台。

'Doctronic proved what we believed from the start: AI can deliver better healthcare outcomes at scale,' said Ramtin Naimi, Partner at Abstract. 'The Utah program validated their clinical rigor. The revenue growth validated market demand. What sets them apart is the courage to take responsibility for outcomes—not just provide information.

“Doctronic证明了我们从一开始就相信的事实：人工智能可以大规模地提供更好的医疗保健结果，”Abstract的合伙人拉姆丁·纳伊米说。“犹他州的项目验证了他们的临床严谨性。收入增长验证了市场需求。让他们与众不同的是敢于对结果负责的勇气——而不仅仅是提供信息。”

That's the future of healthcare.'.

这就是医疗保健的未来。

Lightspeed Venture Partners, which led Doctronic's Series A, doubled down on the investment. 'The combination of user traction, revenue momentum, and partnerships with major health systems makes it clear: Doctronic is the breakout leader in AI-powered medicine,' said Faraz Fatemi, Partner at Lightspeed.

光速创投（Lightspeed Venture Partners）领投了Doctronic的A轮融资，并且加倍了投资。光速合伙人法拉兹·法特米（Faraz Fatemi）表示：“用户吸引力、收入增长势头以及与主要医疗系统的合作伙伴关系，都表明了一点：Doctronic是人工智能驱动医学领域的突破性领导者。”

'They’ve built autonomous AI that integrates safely into real clinical workflows and brings in real patient context—uniquely delivering on the treatment through triage vision at an unmatched scale.'.

“他们构建了能够安全融入真实临床工作流程的自主人工智能，并引入了真实的患者背景——独特地在分诊愿景中实现治疗，且规模无与伦比。”

Founded by Dr. Adam Oskowitz and Matt Pavelle, Doctronic built the first AI system trusted to make clinical decisions autonomously. In December, the company launched prescription renewal services in Utah, allowing patients to receive medication refills directly via AI without a physician intermediary.

由亚当·奥斯科维茨博士和马特·帕维尔创立的Doctronic公司开发了首个可信赖的自主做出临床决策的AI系统。去年12月，该公司在犹他州推出了处方续签服务，允许患者通过AI直接获得药物补充，而无需医生作为中介。

The program handles 190 medications and operates under strict safety protocols including automatic 24/7 escalation to licensed physicians for complex cases..

该程序处理190种药物，并在严格的安全协议下运行，包括自动全天候将复杂病例升级至持证医生处理。

'This round reflects Doctronic’s category leadership: unmatched consumer scale and a best-in-class AI clinical model,' said Pavelle. 'Health systems see us as infrastructure, the digital front door that routes their patients efficiently and keeps care in-network. Payers see us as unlimited primary care at predictable cost.

“这一轮融资反映了Doctronic的品类领导地位：无与伦比的消费者规模和一流的AI临床模型，”帕维尔表示。“卫生系统将我们视为基础设施，是高效引导患者并保持医疗服务在网络内的数字前门。支付方则将我们视为以可预测成本提供的无限初级保健。”

This round lets us push further into academic medical centers, digital health platforms, and payers, while continuing to serve millions of consumers directly.”.

“这一轮让我们进一步深入学术医疗中心、数字健康平台和支付方，同时继续直接服务数百万消费者。”

Doctronic operates its own clinical practice, licensed in all 50 states, HIPAA-compliant, and available 24/7. With direct access to patient records via QHIN/TEFCA, medication history through Surescripts, and drug interaction screening through First Databank, its compounding data advantage and multi-agent model underpin category-leading clinical performance..

Doctronic拥有自己的临床实践机构，在全美50个州均有执业许可，符合HIPAA规定，并提供全天候服务。通过QHIN/TEFCA直接获取患者记录，通过Surescripts获取用药史，并通过First Databank进行药物相互作用筛查，其复合数据优势和多智能体模型支撑了行业领先的临床表现。

The Series B will expand partnerships with hospital systems, academic institutions, digital health platforms, and payers. It will also fund expansion into pediatrics, where consumer demand far outpaces access.

B轮融资将扩大与医院系统、学术机构、数字健康平台和支付方的合作。它还将为扩展到儿科提供资金，因为消费者需求远远超过可获得的服务。

'We're not just faster and cheaper than traditional care — we're more thorough,' said Dr. Oskowitz. 'Our AI performs dozens of safety checks per prescription renewal that would take a human physician an hour. The 99.2% treatment alignment rate isn't theoretical, it's from real patients in real clinical scenarios.

“我们不仅比传统医疗服务更快、更便宜——而且更全面，”奥斯科维茨博士说。“我们的AI在每次处方续签时都会执行数十项安全检查，而这些检查需要人类医生花一个小时才能完成。99.2%的治疗一致率不是理论上的，而是来自真实患者在真实的临床场景中的数据。”

But what I'm most proud of is retention. Since the Series A, monthly repeat physician visits have nearly tripled. Patients aren't just trying us, they're coming back.'.

但最让我自豪的是留存率。自从A轮融资以来，医生每月的重复访问量几乎增加了两倍。患者不仅仅是尝试我们，他们还会回来。

Doctronic is in active discussions with regulators in other states and governments to expand AI prescription services beyond Utah. The company's partnerships now include major health systems, third-party administrators, and self-insured employers.

Doctronic正在与其他州和政府的监管机构进行积极讨论，以将人工智能处方服务扩展到犹他州以外。该公司的合作伙伴现已包括大型卫生系统、第三方管理员以及自保雇主。

Unlike general-purpose AI assistants that provide health information, Doctronic takes responsibility for clinical outcomes. The platform operates on a collective intelligence architecture where multiple specialized AI agents conduct structured clinical reasoning under physician oversight. Each interaction enriches a proprietary dataset that continuously improves diagnostic precision and treatment accuracy.

与提供健康信息的通用人工智能助手不同，Doctronic 对临床结果负责。该平台基于一种集体智能架构运行，多个专业的人工智能代理在医生监督下进行结构化的临床推理。每次互动都会丰富一个专有数据集，该数据集持续提高诊断精确性和治疗准确性。

And where the Doctronic AI is practicing medicine independently, such as in Utah, Doctronic has a first-of-its-kind AI medical malpractice insurance..

在 Doctronic AI 独立行医的地方，比如犹他州，Doctronic 拥有首个专为 AI 设计的医疗事故责任保险。

Doctronic is available 24/7 through its website and mobile apps. AI consultations are always free and deliver patients four potential diagnoses, treatment plans, and clinically formatted documentation for them to use anywhere. If patients choose, Doctronic licensed physicians are also available 24/7 for video visits for insurance copay or only $39..

Doctronic通过其网站和移动应用程序提供全天候服务。人工智能咨询始终免费，为患者提供四种可能的诊断、治疗计划以及可在任何地方使用的临床格式文档。如果患者愿意，Doctronic的持牌医生也提供每周7天、每天24小时的视频问诊服务，支持保险共付或仅需39美元。

About Doctronic

关于Doctronic

Doctronic is the first AI system legally authorized to practice medicine in the United States. Built on a collective intelligence architecture, Doctronic provides free personalized health insights and connects users to licensed providers instantly, affordably, and securely. The company is headquartered in New York City and available across all 50 states..

Doctronic 是美国首个合法授权行医的 AI 系统。基于集体智能架构构建，Doctronic 提供免费的个性化健康见解，并快速、经济、安全地将用户与持牌医疗提供者连接起来。公司总部位于纽约市，服务覆盖全美 50 个州。

For more information, visit: https://www.doctronic.ai

欲了解更多信息，请访问：https://www.doctronic.ai

About Abstract

关于摘要

Abstract is a venture capital firm investing in transformative technology companies. The firm partners with founders building category-defining businesses across AI, infrastructure, and frontier technologies.

Abstract是一家风险投资公司，专注于投资变革性的技术公司。该机构与创始人合作，共同打造在人工智能、基础设施和前沿技术领域定义类别的企业。

About Lightspeed Venture Partners

关于光速创投合作伙伴

Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations in AI, Enterprise, Consumer, Health, and Fintech. Over the past 25 years, Lightspeed has backed hundreds of entrepreneurs and helped build more than 500 companies globally including Anthropic, Epic Games, Affirm, Snap, and Rubrik.

光速创投是一家多阶段的风险投资公司，专注于加速人工智能、企业服务、消费、健康和金融科技领域的颠覆性创新。在过去的25年里，光速创投支持了数百名企业家，并帮助在全球范围内建立了500多家公司，包括Anthropic、Epic Games、Affirm、Snap和Rubrik。

Lightspeed currently manages over $30 billion across its global platform. www.lsvp.com.

光速目前在其全球平台上管理着超过300亿美元的资产。www.lsvp.com。

Contact:

联系：

Media Contact:

媒体联系人：

Cynthia@tusk.vc

辛西娅@tusk.vc